phrykt

Quantum Biopharma Ltd. (QNTM): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of QNTM were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No QNTM insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

QNTM short interest

440,005 QNTM shares are sold short. Over the last 12 reports the number of shares short went up 98%.

As of Oct 30, 2026, 440,005 QNTM shares were sold short, down 15.4% from the report before. At the average daily volume of 97,396 shares, buying them all back would take about 4.5 trading days (days to cover).

Shares short

440,005May 15Oct 30564,728

Days to cover

4.5May 15Oct 305.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026440,005–-15%97,3964.5
Oct 15, 2026519,981–+44%172,0223.0
Sep 30, 2026361,097–+49%226,9011.6
Sep 15, 2026242,498–-7%163,6511.5
Aug 31, 2026261,022–-10%243,6871.1
Aug 14, 2026291,165–-4%347,1631.0
Jul 31, 2026303,789–-10%87,6543.5
Jul 15, 2026339,053–-5%90,0213.8
Jun 30, 2026358,227–+3%165,7332.2
Jun 15, 2026347,301–-16%351,2561.0
May 29, 2026411,604–+86%620,2291.0
May 15, 2026221,665–-22%259,6831.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Famous investors that hold QNTM

1 of the 50 well-known investors we track reported holding QNTM in their latest 13F filing. The largest position is Ken Griffin's, worth $57.1K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202615,863$57.1K0.0%No change

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named QNTM in the last 120 days.

FiledHolderFormStake
Oct 5, 2026AdvisorShares Trust13G/A5.0%
Oct 5, 2026AdvisorShares Trust13G/A5.0%

Questions about Quantum Biopharma Ltd. (QNTM) stock

Are QNTM insiders buying or selling?

No QNTM insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in QNTM?

As of Oct 30, 2026, 440,005 QNTM shares were sold short, down 15.4% from the report before. At the average daily volume of 97,396 shares, buying them all back would take about 4.5 trading days (days to cover). See the history.

Which famous investors hold QNTM?

1 of the 50 well-known investors we track reported QNTM in their latest 13F filing, including Ken Griffin. The largest position is worth $57.1K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.